Abstract
We have reviewed the published literature regarding the effects of CLA on body composition and immune cell functions in humans and in animal models. Results from studies in mice, hamsters, rats, and pigs generally support the notion that CLA reduced depot fat in the normal or lean strains. However, in obese rats, it increased body fat or decreased it less than in the corresponding lean controls. These studies also indicate that t10,c12-CLA was the isomer that reduced adipose fat; however, it also increased the fat content of several other tissues and increased circulating insulin and the saturated FA content of adipose tissue and muscle. Four of the eight published human studies found small but significant reductions in body fat with CLA supplementation; however, the reductions were smaller than the prediction errors for the methods used. The other four human studies found no change in body fat with CLA supplementation. These studies also report that CLA supplementation increased the risk factors for diabetes and cardiovascular disease including increased blood glucose, insulin, insulin resistance, VLDL, C-reactive protein, lipid peroxidation, and decreased HDL. Most studies regarding the effects of CLA on immune cell functions have been conducted with a mixture of isomers, and the results have been variable. One study conducted in mice with the purified c9,t11-CLA and t10,c12-CLA isomers indicated that the two isomers have similar effects on immune cell functions. Some of the reasons for the discrepancies between the effects of CLA in published reports are discussed. Although significant benefit to humans from CLA supplementation is questionable, it may create several health risks in both humans and animals. On the basis of the published data, CLA supplementation of adult human diets to improve body composition or enhance immune functions cannot be recommended at this time.
Similar content being viewed by others
Abbreviations
- BMI:
-
body mass index
- Con A:
-
concanavalin A
- DEXA:
-
dual energy X-ray absorptiometry
- IL:
-
interleukin
- INF:
-
interferon
- LPS:
-
lipopolysaccharide
- MLN:
-
mesenteric lymph node
- PGE2 :
-
prostaglandin E2
- PHA:
-
phytohemagglutinin
- TNF-α:
-
tumor necrosis factor-α
References
Eulitz, K., Yurawecz, M.P., Sehat, N., Fritsche, J., Roach, J.A.G., Mossoba, M.M., Kramer, J.K.G., Adlof, R.O., and Ku, Y. (1999) Preparation, Separation, and Confirmation of the Eight Geometrical cis/trans Conjugated Linoleic Acid Isomers, 8,10-Through 11,13–18∶2, Lipids 34, 873–877.
Kramer, J.K.G., Sehat, N., Dugan, M.E.R., Mossoba, M.M., Yurawecz, M.P., Roach, J.A.G., Eulitz, K., Althaus, J.L., Schaefer, A.L., and Ku, Y. (1998) Distribution of Conjugated Linoleic Acid Isomers in Tissue Lipid Classes of Pigs Fed a Commercial CLA Mixture Determined by Gas Chromatography and Silver Ion High-Performance Liquid Chromatography, Lipids 33, 549–558.
Ha, Y.L., Strokson, J., and Pariza, M.W. (1987) Inhibition of Benzo(α)pyrene-Induced Mouse Forestomach Neoplasia by Conjugated Linoleic Acid, Cancer Res. 50, 1097–1101.
Ip, C., Singh, M., Thompson, H.J., and Scimeca, J.A. (1994) Conjugated Linoleic Acid Suppresses Mammary Carcinogenesis and Proliferative Activity of the Mammary Gland in the Rat, Cancer Res. 54, 1212–1215.
Ip, C., Chin, S.F., Scimeca, J.A., and Pariza, M.W. (1991) Mammary Cancer Prevention by Conjugated Dienoic Derivative of Linoleic Acid, Cancer Res. 51, 6118–6124.
Ip, C., Jiang, C., Thompson, H.J., and Scimeca, J.A. (1997) Retention of Conjugated Linoleic Acid in Mammary Gland Is Associated with Tumor Inhibition During the Post-Initiation Phase of Carcinogenesis, Carcinogenesis 18, 755–759.
Visonneau, S., Cesano, A., Tepper, S.A., Scimeca, J.A., Santoli, D., and Kritchevsky, D. (1997) Conjugated Linoleic Acid Suppresses the Growth of Human Breast Adenocarcinoma Cells in SCID Mice, Anticancer Res. 17, 969–974.
Liew, C., Schut, H.A., Chin, S.F., Pariza, M.W., and Dashwood, R.H. (1995) Protection of Conjugated Linoleic Acids Against 2-Amino-3-methylimidazo[4,5-f]quinoline-Induced Colon Carcinogenesis in F344 Rat: A Study of Inhibitory Mechanisms, Carcinogenesis 16, 3037–3043.
Banni, S., Angioni, E., Casu, V., Melis, M.P., Carta, G., Corngiu, F.P., Thompson, H., and Ip, C. (1999) Decrease in Linoleic Acid Metabolites as a Potential Mechanism in Cancer Risk Reduction by Conjugated Linoleic Acid, Carcinogenesis 20, 1019–1024.
Thompson, H., Zhu, Z., Banni, S., Darcy, K., Loftus, T., and Ip, C. (1997) Morphological and Biochemical Status of the Mammary Gland as Influenced by Conjugated Linoleic Acid: Implications for Reduction of Cancer Risk, Cancer Res. 57, 5067–5072.
Belury, M.A., Bird, C., Nickel, K.P., and Wu, B. (1996) Inhibition of Mouse Skin Tumor Promotion by Dietary Conjugated Linoleate, Nutr. Cancer 26, 149–157.
Cesano, A., Visonneau, S., Scimeca, J.A., Kritchevsky, D., and Santoli, D. (1998) Opposite Effects of Linoleic Acid and Conjugated Linoleic Acid on Human Prostatic Cancer in SCID Mice, Anticancer Res. 18, 1429–1434.
Chew, B.P., Wong, T.S., Schultz, T.D., and Magnuson, N.S. (1997) Effects of Conjugated Dienoic Derivatives of Linoleic Acid and β-Carotene in Modulating Lymphocyte and Macrophage Function, Anticancer Res. 17, 1099–1106.
Schultz, T.D., Chew, B.P., Seaman, W.R., and Leudecke, L.O. (1992) Inhibitory Effects of Conjugated Dienoic Acid and Derivatives of Linoleic Acid and β-Carotene on the in vitro Growth of Human Cancer Cells, Cancer Lett. 63, 125–133.
Lee, K.N., Kritchevsky, D., and Pariza, M.W. (1994) Conjugated Linoleic Acid and Atherosclerosis in Rabbits, Atherosclerosis 108, 19–25.
Nicolosi, R.J., Rogers, E.J., Kritchevsky, D., Scimeca, J.A., and Hut, P.J. (1997) Dietary Conjugated Linoleic Acid Reduces Plasma Lipoproteins and Early Aortic Atherosclerosis in Hypercholesterolemic Hamsters, Artery 22, 266–277.
Wilson, T.A., Nicolosi, R.J., Chrysam, M., and Kritchevsky, D. (2000) Conjugated Linoleic Acid Reduces Early Aortic Atherosclerosis Greater Than Linoleic Acid in Hypercholesterolemic Hamsters, Nutr. Res. 20, 1795–1805.
Houseknecht, K.L., Vanden Heuvel, J.P., Moya-Camarena, S.Y., Portocarrero, C.P., Peck, L.W., Nickel, K.P., and Belury, M.A. (1998) Dietary Conjugated Linoleic Acid Normalizes Impaired Glucose Tolerance in the Zucker Diabetic Fatty fa/fa Rat, Biochem. Biophys. Res. Commun. 244, 678–682.
Park, Y., Storkson, J.M., Albright, K.J., Liu, W., and Pariza, M.W. (1999) Evidence That the trans-10,cis-12 Isomer of Conjugated Linoleic Acid Induces Body Composition Changes in Mice, Lipids 34, 235–241.
Park, Y., Albright, K.J., Liu, W., Storkson, J.M., Cool, M.E., and Pariza, M.W. (1997) Effect of Conjugated Linoleic Acid on Body Composition in Mice, Lipids 32, 853–858.
Terpstra, A.H.M., Beynen, A.C., Everts, H., Kocsis, S., Katan, M.B., and Zock, P.L. (2002) The Decrease in Body Fat in Mice Fed Conjugated Linoleic Acid Is Due to Increases in Energy Expenditure and Energy Loss in the Excreta, J. Nutr. 132, 940–945.
Delany, J.P., Blohm, F., Truett, A.A., Scimeca, J.A., and West, D. (1999) Conjugated Linoleic Acid Rapidly Reduces Body Fat Content in Mice Without Affecting Energy Intake, Am. J. Physiol. 45, R1172-R1179.
Delany, J.P., and West, D. (2000) Changes in Body Composition with Conjugated Linoleic Acid, J. Am. Coll. Nutr. 19, 487S-493S.
West, D.B., Delaney, J.P., Camet, P.M., Blohm, F., Truett, A.A., and Scimeca, J. (1998) Effects of Conjugated Linoleic Acid on Body Composition and Energy Metabolism in Mice, Am. J. Physiol. 275, R667-R672.
Tsuboyama-Kasaoka, N., Takahashi, M., Tanemura, K., Kim, H.-J., Tange, T., Okuyama, H., Kasai, M., Ikemoto, S., and Ezaki, O. (2000) Conjugated Linoleic Acid Supplementation Reduces Adipose Tissue by Apoptosis and Develops Lipodystrophy in Mice, Diabetes 49, 1534–1542.
Gavino, V.C., Gavino, G., Leblanc, J., and Tuchweber, B. (2000) An Isomeric Mixture of Conjugated Linoleic Acid but Not Pure cis-9,trans-11-Octadecadienoic Acid Affects Body Weight Gain and Plasma Lipids in Hamsters, J. Nutr. 130, 27–29.
de Deckere, E.A., van Amelsvoort, J.M., McNeil, G.P., and Jones, P. (1999) Effect of Conjugated Linoleic Acid Isomers on Lipid Level and Peroxisome Proliferation in the Hamster, Br. J. Nutr. 82, 309–317.
Li, Y., and Watkins, B.A. (1998) Conjugated Linoleic Acids Alter Bone Fatty Acid Composition and Reduce ex vivo Bone Prostaglandin E2 Biosynthesis in Rats Fed n−6 and n−3 Fatty Acids, Lipids, 33, 417–425.
Rahman, S.M., Wang, Y.-M., Yotsumoto, H., Cha, J.-Y., Han, S.Y., Inoue, S., and Yanagita, T. (2001) Effect of Conjugated Linoleic Acid on Serum Leptin Concentration, Body-Fat Accumulation, and β-Oxidation of Fatty Acid in OLETF Rats, Nutrition 17, 385–390.
Azain, M.J., Hausman, D.B., Sisk, M.B., Flatt, W.P., and Jewell, D.E. (2000) Dietary Conjugated Linoleic Acid Reduces Rat Adipose Tissue Cell Size Rather than Cell Number, J. Nutr. 130, 1548–1554.
Stangl, G.I. (2000) Conjugated Linoleic Acids Exhibit a Strong Fat-to-Lean Partitioning Effect, Reduce Serum VLDL Lipids and Redistribute Tissue Lipids in Food-Restricted Rats, J. Nutr. 130, 1140–1146.
Sisk, M.B., Hausman, D.B., Martin, R.J., and Azain, M.J. (2001) Dietary Conjugated Linoleic Acid Reduces Adiposity in Lean but Not Obese Zucker Rats, J. Nutr. 131, 1668–1674.
Dugan, M.E.R., Aalus, J.L., Schaefer, A.L., and Kramer, J.K.G. (1997) The Effects of Conjugated Linoleic Acid on Fat and Lean Repartitioning and Feed Conversion in Pigs, Can. J. Anim. Sci. 77, 723–725.
Thiel-Cooper, R.L., Parrish, F.C., Sparks, J.C., Wiegand, B.R., and Ewan, R.C. (2001) Conjugated Linoleic Acid Changes Swine Performance and Carcass Composition, J. Anim. Sci. 79, 1821–1828.
Eggert, J.M., Belury, M.A., Kempa-Steczko, A., Mills, S.E., and Schinckel, A.P. (2001) Effect of Conjugated Linoleic Acid on the Belly Firmness and Fatty Acid Composition of Genetically Lean Pigs, J. Anim. Sci. 79, 2866–2872.
Ramsay, T.G., Evock-Clover, C.M., Steele, N.C., and Azain, M.J. (2001) Dietary Conjugated Linoleic Acid Alters Fatty Acid Composition and Pig Skeletal Muscle Fat, J. Anim. Sci. 79, 2152–2161.
Swan, J.E., Parrish, F.C., Jr., Wiegand, B.R., Larsen, S.T., Bass, T.J., and Berg, E.P. (2001) Total Body Electrical Conductivity (TOBEC) Measurement of Compositional Differences in Hams, Loins, and Bellies from Conjugated Linoleic Acid-Fed Stress-Genotype Pigs, J. Anim. Sci. 79, 1475–1482.
Wiegand, B.R., Parrish, F.C., Jr., Swan, J.E., Larsen, S.T., and Bass, T.J. (2001) Conjugated Linoleic Acid Improves Feed Efficiency, Decreases Subcutaneous Fat, and Improves Certain Aspects of Meat Quality in Stress-Genotype Pigs, J. Anim. Sci. 79, 2187–2195.
Ostrowaska, E., Muralitharan, M., Cross, R.F., Bauman, D.E., and Dunshea, F.R. (1999) Dietary Conjugated Linoleic Acids Increase Fat Deposition in Growing Pigs, J. Nutr. 129, 2037–2042.
Bassaganya-Riera, J., Hontecillas-Margarzo, R., Bregendahl, K., Qannemuehler, M.J., and Zimmerman, D.R. (2001) Effects of Dietary Conjugated Linoleic Acid in Nursery Pigs of Dirty and Clean Environments on Growth, Empty Body Composition, and Immune Competence, J. Anim. Sci. 79, 714–721.
Gatlin, M.A., See, M.T., Larick, D.K., Lin, X., and Odle, J. (2002) Conjugated Linoleic Acid in Combination with Supplemental Dietary Fat Alters Pork Fat Quality, J. Nutr. 132, 3105–3112.
Demaree S.R., Gilbert, C.D., Mersmann, H.J., and Smith, S.B. (2002) Conjugated Linoleic Acid Differently Modifies Fatty Acid Composition in Subcellular Fractions of Muscle and Adipose Tissue but Not Adiposity in Postweanling Pigs, J. Nutr. 132, 3272–3279.
Warren, J.M., Simon, V.A., Bartolini, G., Erickson, K.L., Mackey, B.E., and Kelley, D.S. (2003) Trans-10,cis-12 Conjugated Linoleic Acid Increases Liver and Decreases Adipose Tissue Lipids in Mice: Possible Role of Specific Lipid Metabolism Genes, Lipids (in press).
Miller, C.C., Park, Y., Pariza, M., and Cook, M.E. (1994) Feeding Conjugated Linoleic Acid to Animals Partially Overcame the Catabolic Responses Due to Endotoxin Injection, Biochem. Biophys. Res. Commun. 198, 1107–1112.
Cook, M.E., Miller, C.C., Park, Y., and Pariza, M. (1993) Immune Modulation by Altered Nutrient Metabolism: Nutritional Control of Immune-Induced Growth Depression, Poult. Sci. 72, 1301–1305.
Wong, M.W., Chew, B.P., Wong, T.S., Hosick, H.L., Boylston, T.D., and Schultz, T.D. (1997) Effects of Dietary Conjugated Linoleic Acid on Lymphocyte Function and Growth of Mammary Tumors in Mice, Anticancer Res. 17, 987–994.
Hayek, M.J., Han, S.N., Wu, D., Watkins, B.A., Meydani, M., Dorsey, J.L., Smith, D.E., and Meydani, S.K. (1999) Dietary Conjugated Linoleic Acid Influences the Immune Response of Young and Old C57BL/6NCrIBR Mice, J. Nutr. 129, 32–38.
Turnock, L., Cook, M., Steinberg, H., and Czuprynski, C. (2001) Dietary Supplementation with Conjugated Linoleic Acid Does Not Alter Resistance of Mice to Listeria monocytogenes Infection, Lipids 36, 135–138.
Sugano, M., Tsujita, A., Yamasaki, M., Noguchi, M., and Yamada, K. (1998) Conjugated Linoleic Acid Modulates Tissue Levels of Chemical Mediators and Immunoglobulins, Lipids 33, 521–527.
Yamasaki, M., Kishihara, K., Mansho, K., Ogino, Y., Kasai, M., Sugano, M., Tachibana, H., and Yamada, K. (2000) Dietary Conjugated Linoleic Acid Increases Immunoglobulin Productivity of Sprague-Dawley Rat Splenocytes, Biosci. Biotechnol. Biochem. 64, 2159–2164.
Turek, J.J., Li, Y., Schoenlein, I.A., Allen, K.G.D., and Watkins, B.A. (1998) Modulation of Macrophage Cytokine Production by Conjugated Linoleic Acid Is Influenced by the Dietary n−6∶n−3 Fatty Acid Ratio, J. Nutr. Biochem. 9, 258–266.
Bassaganya-Riera, J., Hontecillas, R., Zimmerman, D.R., and Wannemuehler, M.J. (2001) Dietary Conjugated Linoleic Acid Modulates Phenotype and Effector Functions of Porcine CD8+ Lymphocytes, J. Nutr. 131, 2370–2377.
Bassaganya-Riera, J., Hontecillas, R., Zimmerman, D.R., and Wannemuehler, M.J. (2002) Long-Term Influence of Lipid Nutrition on the Induction of CD8+ Responses to Viral or Bacterial Antigens, Vaccine 20, 1435–1444.
Kelley, D.S., Warren, J.M., Simon, V.A., Bartolini, G., Mackey, B.E., and Erickson, K.L. (2002) Similar Effects of c9,t11-CLA and t10,c12-CLA on Immune Cell Functions in Mice, Lipids 37, 725–728.
Zambell, K.L., Keim, N.L., Van Loan, M.D., Gale, B., Benito, P., Kelley, D.S., and Nelson, G.J. (2000) Conjugated Linoleic Acid Supplementation in Humans: Effects on Body Composition and Energy Expenditure, Lipids 35, 777–782.
Medina, E.A., Horn, W.F., Keim, N.K., Havel, P.J., Benito, P., Kelley, D.S., Nelson, G.J., and Erickson, K.L. (2000) Conjugated Linoleic Acid Supplementation in Humans: Effect on Circulating Leptin Levels and Appetite, Lipids 35, 783–788.
Thom, E., Wadstein, J., and Gudmundsen, O. (2001) Conjugated Linoleic Acid Reduces Body Fat in Healthy Exercising Humans, J. Int. Med. Res. 29, 392–396.
Smedman, A., and Vessby, B. (2001) Conjugated Linoleic Acid Supplementation in Humans—Metabolic Effects, Lipids 36, 773–781.
Atkinson, R.L. (1999) Conjugated Linoleic Acid for Altering Body Composition and Treating Obesity, in Advances in Conjugated Linoleic Acid Research, Volume I (Yurawecz, M.P., Mossaba, M.M., Kramer, J.K.G., Pariza, M.W., and Nelson, G.J., eds.), pp. 348–353, AOCS Press, Champaign.
Blankson, H., Stakkestad, J.A., Fagertun, H., Thom, E., Wadstein, J., and Gudmundsen, O. (2000) Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans, J. Nutr. 130, 2943–2948.
Riserus, U., and Berglund, L. (2001) Conjugated Linoleic Acid Reduced Abdominal Adipose Tissue in Obese Middle-Aged Men with Signs of Metabolic Syndrome: A Randomized Controlled Trial, Int. J. Obes. 25, 1129–1135.
Basu, S., Riserus, U., and Vessby, B. (2000) Conjugated Linoleic Acid Induces Lipid Peroxidation in Men with Abdominal Obesity, Clin. Sci. 99, 511–516.
Riserus, U., Arner, P., Brismar, K., and Vessby, B. (2002) Treatment with Dietary trans-10,cis-12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men with Metabolic Syndrome, Diabetes Care 25, 1516–1521.
Riserus, U., Basu, S., Jovinge, S., Fredrickson, N., Arnlov, J., and Vessby, B. (2002) Supplementation with Conjugated Linoleic Acid Causes Isomer-Dependent Oxidative Stress and Elevated C-Reactive Protein, Circulation 106, 1925–1929.
Kelley, D.S., Taylor, P.C., Rudloph, I.L., Benito, P., Nelson, G.J., Mackey, B.E., and Erickson, K.L. (2000) Dietary Conjugated Linoleic Acid Did Not Alter Immune Status in Young Healthy Women, Lipids 35, 1065–1071.
Kelley, D.S., Simon, V.A., Taylor, P.C., Rudolph, I.L., Benito, P., Nelson, G.J., Mackey, B.E., and Erickson, K. (2001) Dietary Supplementation with Conjugated Linoleic Acid Increased Its Concentration in Human Peripheral Blood Mononuclear Cells, but Did Not Alter Their Function, Lipids 36, 1–6.
Albers, R., van der Willen, R.P.J., Brink, E.J., Hendriks, H.F.J., Dorovska-Taran, V.N., and Mohede, I.C.M. (2003) Effects of cis-9,trans-11 and trans-10,cis-12 Conjugated Linoleic Acid (CLA) Isomers on Immune Function in Healthy Men, Eur. J. Clin. Nutr. 57, 595–603.
Kreider, R.B., Ferreira, M.P., Greenwood, M., Wilson, M., and Almada, A.L. (2002) Effects of Conjugated Linoleic Acid Supplementation During Resistance Training on Body Composition, Bone Density, Strength, and Selected Hematological Markers, J. Strength Cond. Res. 16, 325–334.
Whigham, L.D., Cook, M.E., and Atkinson, R.L. (2000) Conjugated Linoleic Acid: Implications for Human Health, Pharmacol. Res. 42, 503–510.
MacDonald, H.B. (2000) Conjugated Linoleic Acid and Disease Prevention: A Review of Current Knowledge, J. Am. Coll. Nutr. 19, 111S-118S.
Kelly, G.S. (2001) Conjugated Linoleic Acid: A Review, Altern. Med. Rev. 6, 367–382.
Belury, M.A. (2002) Dietary Conjugated Acid in Health: Physiological Effects and Mechanisms of Action, annu. Rev. Nutr. 22, 505–531.
Evans, M.E., Brown, J.M., and McIntosh, M.K. (2002) Isomer-Specific Effects of Conjugated Linoleic Acid (CLA) on Adiposity and Lipid Metabolism, J. Nutr. Biochem. 13, 508–516.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kelley, D.S., Erickson, K.L. Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: Benefits vs. risks. Lipids 38, 377–386 (2003). https://doi.org/10.1007/s11745-003-1072-2
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-003-1072-2